PET

Citations 1-10 of 117 total displayed.

Most recent content (17 Nov 2009):

ARTICLES
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

C. W. Christine, P. A. Starr, P. S. Larson, J. L. Eberling, W. J. Jagust, R. A. Hawkins, H. F. VanBrocklin, J. F. Wright, K. S. Bankiewicz, and M. J. Aminoff
Neurology 2009; 73: 1662-1669. [Abstract] [Full text] [PDF]  

ARTICLES
History of falls in Parkinson disease is associated with reduced cholinergic activity

N. I. Bohnen, M. L.T.M. Müller, R. A. Koeppe, S. A. Studenski, M. A. Kilbourn, K. A. Frey, and R. L. Albin
Neurology 2009; 73: 1670-1676. [Abstract] [Full text] [PDF]  

Past content (since Jun 2001):

ARTICLE
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

C. W. Christine, P. A. Starr, P. S. Larson, J. L. Eberling, W. J. Jagust, R. A. Hawkins, H. F. VanBrocklin, J. F. Wright, K. S. Bankiewicz, and M. J. Aminoff
Neurology first published on October 21, 2009 as doi: WNL.0b013e3181c29356. [Abstract] Rapid PDF  

ARTICLES
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

C. W. Christine, P. A. Starr, P. S. Larson, J. L. Eberling, W. J. Jagust, R. A. Hawkins, H. F. VanBrocklin, J. F. Wright, K. S. Bankiewicz, and M. J. Aminoff
Neurology first published on October 14, 2009 as doi: WNL.0b013e3181c29356. [Abstract] Rapid PDF  

EDITORIALS
Isn’t amyloid more than just a marker for Alzheimer disease?

Ronald J. Killiany
Neurology 2009; 73: 1174-1175. [Full text] [PDF]  

ARTICLES
Follow-up of [¹¹C]PIB uptake and brain volume in patients with Alzheimer disease and controls

N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Någren, S. Helin, M. Scheinin, and J. O. Rinne
Neurology 2009; 73: 1186-1192. [Abstract] [Full text] [PDF]  

ARTICLES
Relationships between biomarkers in aging and dementia

W. J. Jagust, S. M. Landau, L. M. Shaw, J. Q. Trojanowski, R. A. Koeppe, E. M. Reiman, N. L. Foster, R. C. Petersen, M. W. Weiner, J. C. Price, C. A. Mathis For the Alzheimer’s Disease Neuroimaging Initiative
Neurology 2009; 73: 1193-1199. [Abstract] [Full text] [PDF]  

EDITORIALS
Isn't amyloid more than just a marker for Alzheimer disease?

Ronald J. Killiany
Neurology first published on September 9, 2009 as doi: WNL.0b013e3181be020a. Rapid PDF  

ARTICLES
Conversion of amyloid positive and negative MCI to AD over 3 years: An ¹¹C-PIB PET study

A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Någren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, M. N. Rossor, J. O. Rinne, and D. J. Brooks
Neurology 2009; 73: 754-760. [Abstract] [Full text] [PDF]  

ARTICLES
Follow-up of [¹¹C]PIB uptake and brain volume in patients with Alzheimer disease and controls

N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Någren, S. Helin, M. Scheinin, and J. O. Rinne
Neurology first published on September 2, 2009 as doi: WNL.0b013e3181bacf1b. [Abstract] Rapid PDF  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12